166 related articles for article (PubMed ID: 12932249)
1. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.
Willems M; Munte K; Vrolijk JM; Den Hollander JC; Böhm M; Kemmeren MH; De Man RA; Brouwer JT
Br J Dermatol; 2003 Aug; 149(2):390-4. PubMed ID: 12932249
[TBL] [Abstract][Full Text] [Related]
2. Tongue hyperpigmentation during interferon therapy.
Karabay O; Goksugur N; Ogutlu A
J Dermatol; 2011 Mar; 38(3):290-1. PubMed ID: 21342236
[No Abstract] [Full Text] [Related]
3. Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.
Mlika RB; Kerkeni N; Marrak H; Fenniche S; Mokhtar I; Debbiche A
Int J Dermatol; 2013 May; 52(5):643-4. PubMed ID: 23046405
[No Abstract] [Full Text] [Related]
4. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
Farshidi D; Chiu MW
J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
[No Abstract] [Full Text] [Related]
5. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
[No Abstract] [Full Text] [Related]
6. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
Radha Krishna Y; Itha S
Liver Int; 2010 Mar; 30(3):416. PubMed ID: 19422481
[No Abstract] [Full Text] [Related]
7. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Sood A; Midha V; Bansal M; Goyal A; Sharma N
Indian J Gastroenterol; 2006; 25(6):324. PubMed ID: 17264447
[No Abstract] [Full Text] [Related]
8. Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.
Ghosh S; Duseja A; Dhiman RK; Chawla YK
Dig Dis Sci; 2012 Mar; 57(3):820-1. PubMed ID: 21948358
[TBL] [Abstract][Full Text] [Related]
9. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C.
Gurguta C; Kauer C; Bergholz U; Formann E; Steindl-Munda P; Ferenci P
Am J Gastroenterol; 2006 Jan; 101(1):197-8. PubMed ID: 16405555
[TBL] [Abstract][Full Text] [Related]
10. A surprising hyperpigmentation of the gums and tongue.
Dell'Isola S; Ialungo AM; Starnini G; Roselli P; Ghittoni G; Caturelli E
Gut; 2008 Dec; 57(12):1697, 1727. PubMed ID: 19022927
[No Abstract] [Full Text] [Related]
11. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.
Torres HA; Bull L; Arduino RC; Barnett BJ
Am J Gastroenterol; 2007 Jun; 102(6):1334-5. PubMed ID: 17531028
[No Abstract] [Full Text] [Related]
12. Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection.
Tsilika K; Tran A; Trucchi R; Pop S; Anty R; Cardot-Leccia N; Lacour JP; Ortonne JP; Passeron T
JAMA Dermatol; 2013 Jun; 149(6):675-7. PubMed ID: 23553009
[TBL] [Abstract][Full Text] [Related]
13. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report.
de Moraes PC; Noce CW; Thomaz LA; Mautoni MC; Corrêa ME
J Am Dent Assoc; 2009 Nov; 140(11):1377-9. PubMed ID: 19884395
[TBL] [Abstract][Full Text] [Related]
14. Tongue hyperpigmentation during hepatitis C treatment.
Bachmeyer C; Pellen JC
CMAJ; 2012 Sep; 184(13):1498. PubMed ID: 22451683
[No Abstract] [Full Text] [Related]
15. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
Yaşar B; Yaşar Ş; Güneş P
Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
[No Abstract] [Full Text] [Related]
16. Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.
Marcoval J; Notario J; Martín C; Gómez S
Actas Dermosifiliogr; 2014 Mar; 105(2):211-2. PubMed ID: 23623282
[No Abstract] [Full Text] [Related]
17. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
[No Abstract] [Full Text] [Related]
18. Interferon-alpha 2b induced facial erythema in a woman with chronic hepatitis C infection.
Tursen U; Kaya TI; Ikizoglu G
J Eur Acad Dermatol Venereol; 2002 May; 16(3):285-6. PubMed ID: 12195575
[No Abstract] [Full Text] [Related]
19. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
Hashimoto Y; Kanto H; Itoh M
J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Lin J; Lott JP; Amorosa VK; Kovarik CL
J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
